These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18448338)

  • 1. Demonstration of direct binding of cIAP1 degradation-promoting bestatin analogs to BIR3 domain: Synthesis and application of fluorescent bestatin ester analogs.
    Sato S; Aoyama H; Miyachi H; Naito M; Hashimoto Y
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3354-8. PubMed ID: 18448338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation-promoters of cellular inhibitor of apoptosis protein 1 based on bestatin and actinonin.
    Sato S; Tetsuhashi M; Sekine K; Miyachi H; Naito M; Hashimoto Y; Aoyama H
    Bioorg Med Chem; 2008 Apr; 16(8):4685-98. PubMed ID: 18313309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.
    Itoh Y; Ishikawa M; Naito M; Hashimoto Y
    J Am Chem Soc; 2010 Apr; 132(16):5820-6. PubMed ID: 20369832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein.
    Okuhira K; Ohoka N; Sai K; Nishimaki-Mogami T; Itoh Y; Ishikawa M; Hashimoto Y; Naito M
    FEBS Lett; 2011 Apr; 585(8):1147-52. PubMed ID: 21414315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules destabilize cIAP1 by activating auto-ubiquitylation.
    Sekine K; Takubo K; Kikuchi R; Nishimoto M; Kitagawa M; Abe F; Nishikawa K; Tsuruo T; Naito M
    J Biol Chem; 2008 Apr; 283(14):8961-8. PubMed ID: 18230607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of RIP1 ubiquitylation and distribution by MeBS to sensitize cancer cells to tumor necrosis factor α-induced apoptosis.
    Kim S; Ohoka N; Okuhira K; Sai K; Nishimaki-Mogami T; Naito M
    Cancer Sci; 2010 Nov; 101(11):2425-9. PubMed ID: 20825417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
    Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
    Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination.
    Chang YF; Cheng CM; Chang LK; Jong YJ; Yuo CY
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1022-6. PubMed ID: 16510124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
    Taylor A; Peltier CZ; Torre FJ; Hakamian N
    Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin.
    Kim H; Burley SK; Lipscomb WN
    J Mol Biol; 1993 Apr; 230(3):722-4. PubMed ID: 8478928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bestatin, an inhibitor of cell surface proteases, in the interaction of serum with untransformed cells in culture.
    Koren R; Bercovitz H; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1981 Jan; 34(1):90-4. PubMed ID: 7251513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
    Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
    Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bestatin on mouse immune system and experimental murine tumors.
    Ishizuka M; Masuda T; Kanbayashi N; Fukasawa S; Takeuchi T; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1980 Jun; 33(6):642-52. PubMed ID: 7419475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of bestatin-based activity-based probes for metallo-aminopeptidases.
    Harbut MB; Velmourougane G; Reiss G; Chandramohanadas R; Greenbaum DC
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5932-6. PubMed ID: 18823778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the development of bestatin analogues as aminopeptidases inhibitors.
    Chen L; Teng Y; Xu W
    Curr Med Chem; 2011; 18(7):964-76. PubMed ID: 21254977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
    Burley SK; David PR; Lipscomb WN
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogenic effect of bestatin on lymphocytes.
    Ishizuka M; Sato J; Sugiyama Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Jun; 33(6):653-62. PubMed ID: 7419476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bestatin inhibition of human tissue carnosinase, a non-specific cytosolic dipeptidase.
    Peppers SC; Lenney JF
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1281-6. PubMed ID: 3242551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatin.
    Frick L; Wolfenden R
    Biochim Biophys Acta; 1985 Jul; 829(3):311-8. PubMed ID: 3890953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.